US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioAge Labs Inc.

7.75

-0.4300-5.26%

Volume:715.82K

Turnover:5.60M

Market Cap:355.70M

PE:-3.27

High:8.28

Open:8.21

Low:7.62

Close:8.18

52wk High:25.96

52wk Low:4.84

Shares:45.90M

Float Shares:37.58M

Volume Ratio:1.25

T/O Rate:1.90%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3710

EPS(LYR):-2.2432

ROE:-28.21%

ROA:-18.47%

PB:0.95

PE(LYR):-3.45

Loading ...

Overview Company News Filings

Bioage Labs - to Initiate Phase 1B/2a Trial of Bge-102 in Dme in Mid-2026

THOMSON REUTERS

BioAge Labs Shareholders Reelect Directors, Ratify Auditor

BioAge Labs shareholders re-elect three directors at annual meeting

BioAge Labs posts preclinical data on oral NLRP3 inhibitor BGE-102 in diabetic retinopathy model

BioAge Labs posts Phase 1 BGE-102 presentation showing anti-inflammatory activity in obesity cohort

Roth Capital Partners Initiates BioAge Labs at Buy With $36 Price Target

MT Newswires Live

BioAge Labs Initiated at Buy by Roth Capital

BioAge Labs initiated with a Buy at Roth Capital

BioAge Labs joins Jefferies Global Healthcare Conference fireside chat

BioAge Labs to Present at Upcoming Investor Conferences

BTIG Initiates BioAge Labs at Buy With $40 Price Target

MT Newswires Live

BioAge Labs Initiated at Buy by BTIG

BioAge Labs initiated with a Buy at BTIG

Earnings Beat: BioAge Labs, Inc. (NASDAQ:BIOA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, Inc. (LXEO)

BioAge Labs posts R&D Day presentation on BGE-102 program

Calendar of U.S. Earnings Expected in the Week Ahead

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)

BioAge Labs reports Q1 EPS (52c), consensus (63c)

BioAge Labs Reports Q1 GAAP Loss of $0.52 Per Share on $2.8 Million Revenue

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BIOA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BIOA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":7.75,"timestamp":1789588800000,"preClose":8.18,"halted":0,"volume":715815,"delay":0,"changeRate":-0.052567237163814146,"floatShares":37575608,"shares":45896909,"eps":-2.371024,"marketStatus":"Pre-Mkt","change":-0.43,"latestTime":"09-17 04:14:31 EDT","open":8.21,"high":8.275,"low":7.62,"amount":5603464.24335,"amplitude":0.080073,"askPrice":10.85,"askSize":100,"bidPrice":6.42,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.371024,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1727323200000,"exchange":"NASDAQ","adjPreClose":7.75,"postHourTrading":{"tag":"盘后","latestPrice":7.75,"preClose":7.75,"latestTime":"19:42 EDT","volume":16569,"amount":128414.909,"timestamp":1789602159717,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.2513150050431645,"impliedVol":2.3309,"impliedVolPercentile":0.968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOA\",,,,,undefined,":{"symbol":"BIOA","floatShares":37575608,"roa":"-18.47%","roe":"-28.21%","lyrEps":-2.243207,"volumeRatio":1.2513150050431645,"shares":45896909,"dividePrice":0,"high":8.275,"amplitude":0.080073,"preClose":8.18,"low":7.62,"week52Low":4.84,"pbRate":"0.95","psRate":"34.35","week52High":25.955,"institutionHeld":0,"latestPrice":7.75,"eps":-2.371024,"divideRate":0,"volume":715815,"delay":0,"ttmEps":-2.371024,"open":8.21,"prevYearClose":13.23,"prevWeekClose":8.49,"prevMonthClose":9.5,"prevQuarterClose":24.51,"fiveDayClose":9.17,"twentyDayClose":10.46,"sixtyDayClose":21.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"BIOA","fiscalQuarterEnding":"2026/06","expectedEps":-0.65,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2026-05-08","symbol":"BIOA","fiscalQuarterEnding":"2026/03","expectedEps":-0.71,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2026-03-24","symbol":"BIOA","fiscalQuarterEnding":"2025/12","expectedEps":-0.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774324800000,"reportTimeType":"pre","actualEps":-0.72},{"market":"US","date":"2025-11-06","symbol":"BIOA","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.56},{"market":"US","date":"2025-08-06","symbol":"BIOA","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.3333,"hold":0.2222,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":9,"updateTime":1779940800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIOA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIOA","date":"2026-09-15","current":-3.26863,"percent":0.509165,"low":-14.88445,"twenty":-10.359979,"median":-4.290815,"eighty":-2.198286,"high":-1.532635,"avg":-5.88838,"sd":3.934076,"marketCap":389205788},"quantilePoints":[{"date":"2024-09-27","current":-10.065016,"twenty":-9.996853,"median":-9.894609,"eighty":-9.328936,"marketCap":625601139},{"date":"2024-10-04","current":-11.466752,"twenty":-11.453559,"median":-10.988513,"eighty":-9.962772,"marketCap":712727458},{"date":"2024-10-11","current":-11.290848,"twenty":-11.83725,"median":-11.290848,"eighty":-10.377246,"marketCap":701793959},{"date":"2024-10-18","current":-13.247909,"twenty":-12.852074,"median":-11.505231,"eighty":-10.913754,"marketCap":823437060},{"date":"2024-10-25","current":-13.708907,"twenty":-13.699687,"median":-12.032944,"eighty":-11.062173,"marketCap":852090807},{"date":"2024-10-31","current":-14.198716,"twenty":-13.910593,"median":-12.258321,"eighty":-11.163318,"marketCap":882535413},{"date":"2024-11-08","current":-10.411209,"twenty":-13.841443,"median":-12.631325,"eighty":-11.163318,"marketCap":738550334},{"date":"2024-11-15","current":-9.850761,"twenty":-13.741177,"median":-12.203351,"eighty":-10.879672,"marketCap":698793259},{"date":"2024-11-22","current":-9.318711,"twenty":-13.704297,"median":-11.736106,"eighty":-10.071646,"marketCap":661050728},{"date":"2024-11-29","current":-9.500638,"twenty":-13.685857,"median":-11.456511,"eighty":-9.850761,"marketCap":673956274},{"date":"2024-12-06","current":-9.283336,"twenty":-13.657045,"median":-11.290848,"eighty":-9.500638,"marketCap":658541317},{"date":"2024-12-13","current":-2.319571,"twenty":-13.258776,"median":-11.073716,"eighty":-9.298497,"marketCap":164545707},{"date":"2024-12-20","current":-2.612676,"twenty":-13.247909,"median":-10.411209,"eighty":-9.141838,"marketCap":185337975},{"date":"2024-12-27","current":-2.971476,"twenty":-13.224859,"median":-10.152544,"eighty":-7.606575,"marketCap":210790579},{"date":"2025-01-03","current":-2.809763,"twenty":-13.09117,"median":-10.065016,"eighty":-3.032119,"marketCap":199318983},{"date":"2025-01-10","current":-2.572247,"twenty":-12.858367,"median":-9.894609,"eighty":-2.886577,"marketCap":182470076},{"date":"2025-01-17","current":-2.54698,"twenty":-12.632478,"median":-9.680039,"eighty":-2.714757,"marketCap":180677639},{"date":"2025-01-24","current":-2.678371,"twenty":-12.552115,"median":-9.568861,"eighty":-2.625815,"marketCap":189998311},{"date":"2025-01-31","current":-2.415588,"twenty":-12.247327,"median":-9.318711,"eighty":-2.600547,"marketCap":171356967},{"date":"2025-02-07","current":-2.309464,"twenty":-12.16927,"median":-9.263122,"eighty":-2.51868,"marketCap":163828732},{"date":"2025-02-14","current":-2.284196,"twenty":-12.012055,"median":-9.141838,"eighty":-2.417609,"marketCap":162036295},{"date":"2025-02-21","current":-2.223554,"twenty":-11.928501,"median":-8.818412,"eighty":-2.37516,"marketCap":157734447},{"date":"2025-02-28","current":-2.208393,"twenty":-11.54371,"median":-3.087708,"eighty":-2.319571,"marketCap":156658985},{"date":"2025-03-07","current":-2.269035,"twenty":-11.466752,"median":-2.971476,"eighty":-2.294303,"marketCap":160960833},{"date":"2025-03-14","current":-2.122483,"twenty":-11.446271,"median":-2.893147,"eighty":-2.269035,"marketCap":150564699},{"date":"2025-03-21","current":-2.208204,"twenty":-11.43377,"median":-2.779442,"eighty":-2.233661,"marketCap":157023162},{"date":"2025-03-28","current":-1.956126,"twenty":-11.290848,"median":-2.7188,"eighty":-2.233661,"marketCap":139098143},{"date":"2025-04-04","current":-1.714131,"twenty":-11.203915,"median":-2.693532,"eighty":-2.213447,"marketCap":121890125},{"date":"2025-04-11","current":-1.729255,"twenty":-11.131435,"median":-2.645523,"eighty":-2.198286,"marketCap":122965626},{"date":"2025-04-17","current":-1.890585,"twenty":-11.039085,"median":-2.589935,"eighty":-2.192221,"marketCap":134437638},{"date":"2025-04-25","current":-2.117456,"twenty":-10.879672,"median":-2.54698,"eighty":-2.170997,"marketCap":150570155},{"date":"2025-05-02","current":-2.087206,"twenty":-10.498085,"median":-2.486337,"eighty":-2.155781,"marketCap":148419153},{"date":"2025-05-09","current":-2.073948,"twenty":-10.229442,"median":-2.420641,"eighty":-2.117456,"marketCap":147343652},{"date":"2025-05-16","current":-1.927611,"twenty":-10.158835,"median":-2.377687,"eighty":-2.112406,"marketCap":136947141},{"date":"2025-05-23","current":-2.038626,"twenty":-10.109042,"median":-2.344838,"eighty":-2.086198,"marketCap":144834149},{"date":"2025-05-30","current":-2.008349,"twenty":-10.078276,"median":-2.334731,"eighty":-2.073148,"marketCap":142683147},{"date":"2025-06-06","current":-2.24047,"twenty":-9.99928,"median":-2.314518,"eighty":-2.051746,"marketCap":159174164},{"date":"2025-06-13","current":-2.2657,"twenty":-9.918948,"median":-2.294303,"eighty":-2.064674,"marketCap":160966666},{"date":"2025-06-20","current":-2.215239,"twenty":-9.87707,"median":-2.284196,"eighty":-2.072748,"marketCap":157381662},{"date":"2025-06-27","current":-2.200101,"twenty":-9.785504,"median":-2.271562,"eighty":-2.073948,"marketCap":156306161},{"date":"2025-07-03","current":-2.159732,"twenty":-9.684587,"median":-2.26468,"eighty":-2.075591,"marketCap":153438158},{"date":"2025-07-11","current":-2.361576,"twenty":-9.665383,"median":-2.263661,"eighty":-2.08254,"marketCap":167778173},{"date":"2025-07-18","current":-2.422129,"twenty":-9.609795,"median":-2.271562,"eighty":-2.08404,"marketCap":172080177},{"date":"2025-07-25","current":-2.371668,"twenty":-9.500638,"median":-2.280838,"eighty":-2.084673,"marketCap":168495173},{"date":"2025-08-01","current":-2.220285,"twenty":-9.464253,"median":-2.280838,"eighty":-2.088197,"marketCap":157740162},{"date":"2025-08-08","current":-1.959737,"twenty":-9.314668,"median":-2.269035,"eighty":-2.084673,"marketCap":154872159},{"date":"2025-08-15","current":-2.023247,"twenty":-9.295465,"median":-2.262157,"eighty":-2.074957,"marketCap":159891165},{"date":"2025-08-22","current":-2.041393,"twenty":-9.27525,"median":-2.258928,"eighty":-2.064982,"marketCap":161325166},{"date":"2025-08-29","current":-2.177486,"twenty":-9.225726,"median":-2.244642,"eighty":-2.064982,"marketCap":172080177},{"date":"2025-09-05","current":-2.136658,"twenty":-9.156998,"median":-2.24047,"eighty":-2.068612,"marketCap":168853674},{"date":"2025-09-12","current":-2.227387,"twenty":-9.141838,"median":-2.24047,"eighty":-2.071948,"marketCap":176023681},{"date":"2025-09-19","current":-2.368016,"twenty":-8.95182,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-09-26","current":-2.368016,"twenty":-8.818412,"median":-2.24047,"eighty":-2.073948,"marketCap":187137193},{"date":"2025-10-03","current":-2.676493,"twenty":-8.732502,"median":-2.244642,"eighty":-2.078994,"marketCap":211515218},{"date":"2025-10-10","current":-2.472354,"twenty":-3.102868,"median":-2.258928,"eighty":-2.082165,"marketCap":195382701},{"date":"2025-10-17","current":-2.318115,"twenty":-3.072547,"median":-2.260654,"eighty":-2.08404,"marketCap":183193689},{"date":"2025-10-24","current":-3.606461,"twenty":-3.072547,"median":-2.2657,"eighty":-2.08404,"marketCap":285007794},{"date":"2025-10-31","current":-3.50666,"twenty":-3.483977,"median":-2.271562,"eighty":-2.087206,"marketCap":277120786},{"date":"2025-11-07","current":-3.533398,"twenty":-3.483977,"median":-2.280838,"eighty":-2.091294,"marketCap":267799776},{"date":"2025-11-14","current":-3.65216,"twenty":-3.543352,"median":-2.287377,"eighty":-2.091294,"marketCap":276800885},{"date":"2025-11-21","current":-4.063738,"twenty":-3.690007,"median":-2.299357,"eighty":-2.092162,"marketCap":307994767},{"date":"2025-11-28","current":-4.489508,"twenty":-3.899107,"median":-2.309042,"eighty":-2.092231,"marketCap":340264301},{"date":"2025-12-05","current":-4.967317,"twenty":-4.069415,"median":-2.318115,"eighty":-2.105866,"marketCap":376477888},{"date":"2025-12-12","current":-6.031742,"twenty":-4.3315,"median":-2.319571,"eighty":-2.109405,"marketCap":457151721},{"date":"2025-12-19","current":-5.856703,"twenty":-5.07234,"median":-2.333015,"eighty":-2.111789,"marketCap":443885358},{"date":"2025-12-26","current":-6.660935,"twenty":-5.750734,"median":-2.336346,"eighty":-2.112399,"marketCap":504838920},{"date":"2026-01-02","current":-6.258819,"twenty":-5.908741,"median":-2.336346,"eighty":-2.11442,"marketCap":474362139},{"date":"2026-01-09","current":-6.585243,"twenty":-6.05445,"median":-2.344838,"eighty":-2.11744,"marketCap":499102115},{"date":"2026-01-16","current":-10.175903,"twenty":-6.388442,"median":-2.355734,"eighty":-2.117456,"marketCap":771241845},{"date":"2026-01-23","current":-10.411813,"twenty":-6.562534,"median":-2.368016,"eighty":-2.117456,"marketCap":789121720},{"date":"2026-01-30","current":-10.521991,"twenty":-6.660935,"median":-2.37516,"eighty":-2.117837,"marketCap":797472215},{"date":"2026-02-06","current":-11.006774,"twenty":-8.674889,"median":-2.403126,"eighty":-2.119987,"marketCap":834214390},{"date":"2026-02-13","current":-10.984738,"twenty":-9.153966,"median":-2.415588,"eighty":-2.124502,"marketCap":832544291},{"date":"2026-02-20","current":-11.094916,"twenty":-9.298497,"median":-2.422129,"eighty":-2.13258,"marketCap":840894786},{"date":"2026-02-27","current":-12.295855,"twenty":-9.537248,"median":-2.429257,"eighty":-2.136658,"marketCap":931915175},{"date":"2026-03-06","current":-11.22713,"twenty":-9.787979,"median":-2.458744,"eighty":-2.147751,"marketCap":850915379},{"date":"2026-03-13","current":-10.954439,"twenty":-10.064753,"median":-2.474292,"eighty":-2.150267,"marketCap":830247905},{"date":"2026-03-20","current":-11.590717,"twenty":-10.152544,"median":-2.496444,"eighty":-2.150267,"marketCap":878472010},{"date":"2026-03-27","current":-8.946976,"twenty":-10.175903,"median":-2.526002,"eighty":-2.154686,"marketCap":721170986},{"date":"2026-04-02","current":-9.761839,"twenty":-10.157216,"median":-2.545959,"eighty":-2.157168,"marketCap":786853020},{"date":"2026-04-10","current":-9.794874,"twenty":-10.109042,"median":-2.572155,"eighty":-2.15903,"marketCap":789515805},{"date":"2026-04-17","current":-9.354407,"twenty":-10.088448,"median":-2.581791,"eighty":-2.159654,"marketCap":754012003},{"date":"2026-04-24","current":-9.492053,"twenty":-10.157216,"median":-2.612676,"eighty":-2.159732,"marketCap":765106941},{"date":"2026-05-01","current":-9.281102,"twenty":-10.117474,"median":-2.677432,"eighty":-2.159732,"marketCap":748103216},{"date":"2026-05-08","current":-9.815385,"twenty":-10.117474,"median":-2.685566,"eighty":-2.162275,"marketCap":791169098},{"date":"2026-05-15","current":-9.250894,"twenty":-10.100274,"median":-2.711219,"eighty":-2.168441,"marketCap":831932916},{"date":"2026-05-22","current":-8.274644,"twenty":-10.088448,"median":-2.728907,"eighty":-2.172379,"marketCap":744138767},{"date":"2026-05-29","current":-8.427879,"twenty":-10.073417,"median":-2.779442,"eighty":-2.173018,"marketCap":757919114},{"date":"2026-06-05","current":-8.413049,"twenty":-10.064858,"median":-2.893147,"eighty":-2.175699,"marketCap":756585532},{"date":"2026-06-12","current":-8.131296,"twenty":-9.999175,"median":-2.971476,"eighty":-2.177486,"marketCap":731247474},{"date":"2026-06-18","current":-9.881131,"twenty":-10.021034,"median":-3.072547,"eighty":-2.177486,"marketCap":888610152},{"date":"2026-06-26","current":-11.18115,"twenty":-10.10449,"median":-3.377371,"eighty":-2.17969,"marketCap":1005520843},{"date":"2026-07-02","current":-11.991808,"twenty":-10.16483,"median":-3.4182,"eighty":-2.183022,"marketCap":1078423326},{"date":"2026-07-10","current":-12.30322,"twenty":-10.247258,"median":-3.447686,"eighty":-2.183492,"marketCap":1106428549},{"date":"2026-07-17","current":-10.953771,"twenty":-10.359979,"median":-3.495318,"eighty":-2.185281,"marketCap":985072585},{"date":"2026-07-24","current":-10.825252,"twenty":-10.509871,"median":-3.543352,"eighty":-2.186883,"marketCap":973514874},{"date":"2026-07-31","current":-12.283448,"twenty":-10.632169,"median":-3.606461,"eighty":-2.188179,"marketCap":1104650439},{"date":"2026-08-07","current":-5.30342,"twenty":-10.612701,"median":-3.697103,"eighty":-2.190009,"marketCap":500982312},{"date":"2026-08-14","current":-5.067589,"twenty":-10.521991,"median":-3.898161,"eighty":-2.190009,"marketCap":478704760},{"date":"2026-08-21","current":-4.708048,"twenty":-10.461393,"median":-3.973853,"eighty":-2.193232,"marketCap":444741048},{"date":"2026-08-28","current":-4.897536,"twenty":-10.411813,"median":-4.092123,"eighty":-2.193232,"marketCap":462640842},{"date":"2026-09-04","current":-4.615733,"twenty":-10.411209,"median":-4.290815,"eighty":-2.195055,"marketCap":436020635},{"date":"2026-09-11","current":-4.202747,"twenty":-10.372028,"median":-4.342854,"eighty":-2.19764,"marketCap":397008262},{"date":"2026-09-15","current":-4.120149,"twenty":-10.359979,"median":-4.290815,"eighty":-2.198286,"marketCap":389205788}],"updateTime":1789632871413},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIOA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643375404","title":"Bioage Labs - to Initiate Phase 1B/2a Trial of Bge-102 in Dme in Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643375404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643375404?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:00","pubTimestamp":1781611201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUABNWHLK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642298022","title":"BioAge Labs Shareholders Reelect Directors, Ratify Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2642298022","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642298022?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:34","pubTimestamp":1781267666,"startTime":"0","endTime":"0","summary":"The latest announcement is out from BioAge Labs, Inc. ( ($BIOA) ). On June 10, 2026, BioAge Labs, Inc. stockholders elected three Class II director...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioage-labs-shareholders-reelect-directors-ratify-auditor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioage-labs-shareholders-reelect-directors-ratify-auditor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642260070","title":"BioAge Labs shareholders re-elect three directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642260070","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642260070?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:02","pubTimestamp":1781265724,"startTime":"0","endTime":"0","summary":"BioAge Labs held its 2026 annual stockholder meeting on June 10, 2026.Stockholders elected Patrick Enright, James I. Healy, Rekha Hemrajani as Class II directors; the election was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL6PBk6t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642588684","title":"BioAge Labs posts preclinical data on oral NLRP3 inhibitor BGE-102 in diabetic retinopathy model","url":"https://stock-news.laohu8.com/highlight/detail?id=2642588684","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642588684?lang=en_us&edition=fundamental","pubTime":"2026-06-09 08:30","pubTimestamp":1780965038,"startTime":"0","endTime":"0","summary":"BioAge Labs published preclinical results for oral NLRP3 inhibitor BGE-102 in a streptozotocin-induced diabetic retinopathy mouse model.BGE-102 cut retinal vascular permeability versus vehicle by 74% at 20 mg/kg, 98.7% at 50 mg/kg; higher dose restored angiography to healthy levels.Claudin-5 staining showed tight-junction integrity restored to 95% to 97% of healthy control levels despite persistent hyperglycemia.Findings support a planned Phase 1b/2a trial in diabetic macular edema.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original content used to generate this news brief on June 07, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL4Ztx5d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642430920","title":"BioAge Labs posts Phase 1 BGE-102 presentation showing anti-inflammatory activity in obesity cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2642430920","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642430920?lang=en_us&edition=fundamental","pubTime":"2026-06-09 08:09","pubTimestamp":1780963767,"startTime":"0","endTime":"0","summary":"BioAge Labs released a medical research presentation on Phase 1 results for BGE-102, an oral NLRP3 inhibitor studied in healthy volunteers and participants with obesity.Trial readouts showed 90% ex vivo IL-1β suppression at trough at 60 mg, rising to 98% at 120 mg after 14 days.In a 120 mg multiple-ascending-dose cohort in obesity, hsCRP fell 86% at Day 14 versus 43% on placebo; 93% reached hsCRP below 2 mg/L.Safety profile showed mild-to-moderate adverse events with no serious events, no discontinuations, no dose-limiting toxicities.Data package supports moving BGE-102 into proof-of-concept studies targeting metabolic and inflammatory conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL9GrDJV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638501627","title":"Roth Capital Partners Initiates BioAge Labs at Buy With $36 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2638501627","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638501627?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:41","pubTimestamp":1779878494,"startTime":"0","endTime":"0","summary":"BioAge Labs (BIOA) has an average rating of buy and mean price target of $49.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638509976","title":"BioAge Labs Initiated at Buy by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2638509976","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638509976?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:18","pubTimestamp":1779877080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2026 06:18 ET (10:18 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638570432","title":"BioAge Labs initiated with a Buy at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2638570432","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638570432?lang=en_us&edition=fundamental","pubTime":"2026-05-27 16:20","pubTimestamp":1779870008,"startTime":"0","endTime":"0","summary":"Roth Capital analyst Adam Walsh initiated coverage of BioAge Labs (BIOA) with a Buy rating and $36 price target The firm believes the company’s lea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637314726","title":"BioAge Labs joins Jefferies Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2637314726","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637314726?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:00","pubTimestamp":1779454857,"startTime":"0","endTime":"0","summary":"BioAge Labs will attend the Jefferies Global Healthcare Conference in New York on June 3-4, 2026.A fireside chat is scheduled for June 4, 2026, from 3:45-4:15 p.m. EDT.The company will also attend the Goldman Sachs Global Healthcare Conference in Miami Beach on June 8-10, 2025, with a fireside chat set for June 8, 2025, from 2:40-3:15 p.m. EDT.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDLcclySm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836757.USD","BIOA","LU0942090050.USD","LU1894683348.USD","IE00B19Z3581.USD","SG9999014005.SGD","BK4127","LU2095319765.USD","LU2237438978.USD","LU1804176565.USD","IE00BN0W2T93.GBP","LU2750360997.AUD","SG9999014013.SGD","LU2471134879.HKD","LU1868836591.USD","LU1868837136.USD","IE00B64PRP62.GBP","LU2265009873.SGD","LU1668664300.SGD","LU0345770308.USD","LU2237443978.SGD","LU2210149790.SGD","IE00BSNM7G36.USD","LU2750360641.GBP","LU0345770993.USD","IE00BKPKM429.USD","LU0742534661.SGD","IE0004086264.USD","IE0004091025.USD","LU1791807156.HKD","LU1868837300.USD","LU0314104364.USD","LU2237443549.SGD","BK4112","LU1894683264.USD","IE0002270589.USD","BK4007","IE00B3QW5Z07.USD","BK4552","LU0251131958.USD","IE00BN0W2V16.EUR","LU2237443622.USD","NDAQ","GSX","LU0106831901.USD","LU2210150020.SGD","LU0061475181.USD","LU2471134796.USD","LU0868494708.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637312872","title":"BioAge Labs to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312872","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637312872?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:00","pubTimestamp":1779454800,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., May  22, 2026  (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) (\"BioAge\", \"the Company\"), a clinical-stage biotechnology company developing therapeutic product candidates for ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/22/3300131/0/en/BioAge-Labs-to-Present-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635786774","title":"BTIG Initiates BioAge Labs at Buy With $40 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2635786774","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635786774?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:13","pubTimestamp":1778670802,"startTime":"0","endTime":"0","summary":"BioAge Labs (BIOA) has an average rating of overweight and mean price target of $51.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635368783","title":"BioAge Labs Initiated at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2635368783","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635368783?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:26","pubTimestamp":1778667960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BIOA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2026 06:26 ET (10:26 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635200797","title":"BioAge Labs initiated with a Buy at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2635200797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635200797?lang=en_us&edition=fundamental","pubTime":"2026-05-13 17:55","pubTimestamp":1778666109,"startTime":"0","endTime":"0","summary":"BTIG initiated coverage of BioAge Labs (BIOA) with a Buy rating and $40 price target BioAge is a clinical-stage biopharmaceutical company focused o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634213137","title":"Earnings Beat: BioAge Labs, Inc. (NASDAQ:BIOA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2634213137","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634213137?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:37","pubTimestamp":1778582225,"startTime":"0","endTime":"0","summary":"A week ago, BioAge Labs, Inc. ( NASDAQ:BIOA ) came out with a strong set of first-quarter numbers that could...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/earnings-beat-bioage-labs-inc-nasdaqbioa-just-beat-analyst-f","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bioa/bioage-labs/news/earnings-beat-bioage-labs-inc-nasdaqbioa-just-beat-analyst-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":[".IXIC","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634313802","title":"Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, Inc. (LXEO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634313802","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634313802?lang=en_us&edition=fundamental","pubTime":"2026-05-12 02:20","pubTimestamp":1778523612,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, I...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-lexeo-therapeutics-inc-lxeo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-lexeo-therapeutics-inc-lxeo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BIOA","XBI","LU0029874061.USD","BK4581","BK4139","BK4585","XLV","HCSG","LABU","LXEO","BK4588","BK4007","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634236426","title":"BioAge Labs posts R&D Day presentation on BGE-102 program","url":"https://stock-news.laohu8.com/highlight/detail?id=2634236426","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634236426?lang=en_us&edition=fundamental","pubTime":"2026-05-12 01:10","pubTimestamp":1778519453,"startTime":"0","endTime":"0","summary":"BioAge Labs published an R&D Day presentation highlighting Phase 1 results for lead program BGE-102, an oral brain-penetrant NLRP3 inhibitor positioned for cardiometabolic disease.Presentation flagged 86% hsCRP reduction in obese subjects, with 87-93% achieving normalized hsCRP below 2 mg/L.Program profile included 24-hour IL-1β suppression of at least 90% at 60 mg once daily, with CNS penetration reported at about 0.7 Kp,uu CSF at 120 mg multiple ascending dose on day 14.Update outlined upcoming proof-of-concept readouts for cardiovascular risk in H2 2026, with diabetic macular edema proof-of-concept targeted for mid-2027.Company also highlighted an APJ agonist obesity program, with IND submission targeted for year-end 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL2rQJhj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634020034","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2634020034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634020034?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:00","pubTimestamp":1778493600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·ATL Braves C                                   1Q      (.78)   8:00 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX","DCGO","BIOA","ABCL","ACET","ARMK","BCSF","BGS","CGBD","CBLL","CEG","BATRK","CLSK","APC","BODI","AEYE","CDRE","CERT","BATRA","ACHV","AIP","AMTM","COOK","AGNT","ANDG","APEI","CEVA","BLNK","ACH","BALY","CINT","BTAI","ALLT","BETA","AMBQ","B","ACM","BCAX","CLLS","ASTS","ACRS","ABOS","ALGS","ATRO","ASRT","BRCB","CHRS","ARVN","CRCL","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634440448","title":"Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634440448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634440448?lang=en_us&edition=fundamental","pubTime":"2026-05-10 21:50","pubTimestamp":1778421041,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-bioage-labs-inc-bioa-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amylyx-pharmaceuticals-inc-amlx-bioage-labs-inc-bioa-and-pharvaris-phvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BIOA","BK4585","BK4581","LABU","HCSG","BK4588","XLV","LU0029874061.USD","PHVS","AMLX","BK4007","LU0128526141.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633092450","title":"BioAge Labs reports Q1 EPS (52c), consensus (63c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633092450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633092450?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:21","pubTimestamp":1778253689,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $2.77M, consensus $1.08M. “The positive topline Phase 1 data we reported for BGE-102 in April reinforce our conviction that we h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-reports-q1-eps-52c-consensus-63c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-reports-q1-eps-52c-consensus-63c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143337615","title":"BioAge Labs Reports Q1 GAAP Loss of $0.52 Per Share on $2.8 Million Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1143337615","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143337615?lang=en_us&edition=fundamental","pubTime":"2026-05-08 22:51","pubTimestamp":1778251918,"startTime":"0","endTime":"0","summary":"Clinical-stage biotechnology company BioAge Labs Inc. has announced its financial results for the first quarter of 2026, reporting a GAAP loss per share of $0.52 and revenue of $2.8 million. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","UDN","UUP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":98,"code":"91000000","status":"200"}]}}